Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,445 | 2,903 | 3,261 | 3,542 | 2,621 |
| Operating Income | -3,445 | -2,903 | -3,261 | -3,542 | -2,621 |
| Pre-tax Income | -3,445 | -2,903 | -3,261 | -3,542 | -2,621 |
| Net Income Continuous | -3,445 | -2,903 | -3,261 | -3,542 | -2,621 |
| Net Income | $-3,445 | $-2,903 | $-3,261 | $-3,542 | $-2,621 |
| EPS Basic Total Ops | -0.28 | -0.25 | -0.28 | -0.32 | -0.26 |
| EPS Basic Continuous Ops | -0.28 | -0.25 | -0.28 | -0.32 | -0.26 |
| EPS Diluted Total Ops | -0.28 | -0.25 | -0.28 | -0.32 | -0.26 |
| EPS Diluted Continuous Ops | -0.28 | -0.25 | -0.28 | -0.32 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.25 | -0.28 | -0.32 | N/A |
| EBITDA(a) | $-3,445 | $-2,903 | $-3,261 | $-3,542 | $-2,621 |